Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 6, 2012, Pages 411-417

  Wang, Li Hui ^a,b   Yen, Chia Liang ^c   Chang, Tsung Chain ^c   Liu, Ching Chuan ^a   Shieh, Chi Chang ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b KUO GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Autosomal dominant interferon receptor 1 deficiency; Mycobacterial infection; Oligonucleotide array; Primary immunodeficiency disease

Indexed keywords

AMIKACIN; AUTOANTIBODY; AZITHROMYCIN; CELL SURFACE MARKER; CELL SURFACE RECEPTOR; CIPROFLOXACIN; CLARITHROMYCIN; COMPLEMENTARY DNA; ETHAMBUTOL; GALLIUM; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; INTERLEUKIN 12; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANAMNESIS; ARTICLE; BONE BIOPSY; CASE REPORT; CHILD; CYTOKINE RELEASE; DNA MICROARRAY; DNA SEQUENCE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; INFANT; INTRACELLULAR SIGNALING; MALE; MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE; MOLECULAR DIAGNOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; THORAX RADIOGRAPHY;

ADULT; AMINO ACID SEQUENCE; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, INTERFERON; SEQUENCE ANALYSIS, DNA;

EID: 84870295629     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.08.017     Document Type: Article

References (23)

1. Casanova J.L., Jouanguy E., Lamhamedi S., Blanche S., Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995, 346:581.
2. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006, 18:347-361.
3. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581-620.
4. Chou C.H., Chen H.Y., Chen C.Y., Huang C.T., Lai C.C., Hsueh P.R. Clinical features and outcomes of disseminated infections caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 2004-2008. Scand J Infect Dis 2011, 43:8-14.
5. Patel A., Shah N. Mycobacterium avium subsp. paratuberculosis - incidences in milk and milk products, their isolation, enumeration, characterization, and role in human health. J Microbiol Immunol Infect 2011, 44:473-479.
6. Tan C.K., Lai C.C., Lin S.H., Huang Y.T., Liao C.H., Hsueh P.R. Diagnostic utility of enzyme-linked immunospot assay for interferon-gamma in a patient with tuberculous arthritis and pyomyositis. J Microbiol Immunol Infect 2011, 44:397-400.
7. Patel S.Y., Ding L., Brown M.R., Lantz L., Gay T., Cohen S., et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005, 175:4769-4776.
8. Kampmann B., Hemingway C., Stephens A., Davidson R., Goodsall A., Anderson S., et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005, 115:2480-2488.
9. Hoflich C., Sabat R., Rosseau S., Temmesfeld B., Slevogt H., Docke W.D., et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004, 103:673-675.
10. Browne S.K., Holland S.M. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis 2010, 10:875-885.
11. Chen Y.P., Yen Y.S., Chen T.Y., Yen C.L., Shieh C.C., Chang K.C. Systemic Mycobacterium kansasii infection mimicking peripheral T-cell lymphoma. APMIS 2008, 116:850-858.
12. Al-Muhsen S., Casanova J.L. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008, 122:1043-1051.
13. Jouanguy E., Lamhamedi-Cherradi S., Lammas D., Dorman S.E., Fondaneche M.C., Dupuis S., et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999, 21:370-378.
14. Lawrence T., Puel A., Reichenbach J., Ku C.L., Chapgier A., Renner E., et al. Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol 2005, 12:22-30.
15. Bustamante J., Arias A.A., Vogt G., Picard C., Galicia L.B., Prando C., et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 2011, 12:213-221.
16. Chang J.T., Dou H.Y., Yen C.L., Wu Y.H., Huang R.M., Lin H.J., et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011, 110:372-381.
17. Gough D.J., Levy D.E., Johnstone R.W., Clarke C.J. IFNgamma signaling - does it mean JAK-STAT?. Cytokine Growth Factor Rev 2008, 19:383-394.
18. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011, 208:1635-1648.
19. Liu Y.C., Shin-Jung L.S., Chen Y.S., Tu H.Z., Chen B.C., Huang T.S. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. J Microbiol Immunol Infect 2011, 44:88-94.
20. McGrath E.E., Anderson P.B. Increased prevalence of non-tuberculous mycobacteria infection. Lancet 2007, 370:28.
21. Park H., Jang H., Song E., Chang C.L., Lee M., Jeong S., et al. Detection and genotyping of Mycobacterium species from clinical isolates and specimens by oligonucleotide array. J Clin Microbiol 2005, 43:1782-1788.
22. Bouchara J.P., Hsieh H.Y., Croquefer S., Barton R., Marchais V., Pihet M., et al. Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J Clin Microbiol 2009, 47:142-152.
23. Hung W.T., Su S.L., Shiu L.Y., Chang T.C. Rapid identification of allergenic and pathogenic molds in environmental air by an oligonucleotide array. BMC Infect Dis 2011, 11:91.